1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

2015 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

  • June 2015
  • -
  • Venture Planning Group
  • -
  • 565 pages

Summary

Table of Contents

Complete report $6,700.  DataPack (test volumes, sales forecasts, supplier shares) $4,350.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. 


2015 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is VPGMarketResearch’s new study of the major business opportunities emerging in the Spanish cancer diagnostics market during the next five years.  The report examines trends in the Spanish market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.  


Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.  During the next five years, the Spanish cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.  Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.  The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.


Spanish Market Overview


- Five-year test volume and sales projections.


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers.


- Estimated universe of laboratories performing cancer diagnostic testing.


- Cancer statistics, etiology and recent developments in Spain.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Over 200 Current and Emerging Cancer Diagnostic Test


- Oncogenes

- Biochemical Markers

- Growth Factors

- Colony Stimulating Factors

- Hormones

- Immunohistochemical Stains

- Lymphokines


Supplier Shares, Sales and Volume Forecasts


- Sales and market shares of major cancer diagnostic product

suppliers by individual test.


- Five-year test volume and sales forecasts

for major tumor markers by market segment, including:


º  Hospitals

º  Commercial/Private Laboratories



Instrumentation Review


- Analysis of major molecular diagnostic and immunodignostic analyzers

used for cancer testing, including their operating characteristics,

features and selling prices.


Technology Assessment


- Assessment of latest technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies.


- Extensive listings of companies, universities

and research centers developing new cancer diagnostic tests

and detection technologies.


Competitive Strategies


- Strategic assessments of major suppliers

and start-up firms developing innovative cancer diagnostic

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - AdnaGen

   - Agilent Technologies

   - Applied Gene Technologies

   - Arca Pharma

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biomedical Diagnostics

   - bioMerieux

   - Bio-Rad

   - CellSearch

   - Cepheid

   - Correlogic Systems/Vermillion

   - Decode Genetics

   - Diadexus

   - Diagnocure

   - DiaSorin

   - Eiken Chemical

   - Elitech Group

   - Epigenomics

   - Enterix

   - Enzo Biochem

   - Exact Sciences

   - Fujirebio

   - Guided Therapeutics

   - Hologic/Gen-Probe

   - Kreatech/Leica

   - Kyowa Medex

   - Mackay Life Sciences

   - Myriad Genetics

   - OncoLab

   - Ortho-Clinical Diagnostics

   - Panacea Pharmaceuticals

   - Polartechnics

   - Polymedco

   - PreMD

   - Qiagen/Ipsogen

   - Quest Diagnostics

   - Radient Pharmaceuticals

   - Roche

   - Scienion

   - Sequenom

   - Siemens Healthcare

   - Takara Bio

   - Targeted Diagnostics & Therapeutics

   - Thermo Fisher

   - Tosoh

   - Veridex

   - Wako Pure Chemicals

   - Wallac/PE

   - Zilla


Contains 565 pages and 85 tables

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2015 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is VPGMarketResearch’s new study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics 2021: Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2021: Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


Download Unlimited Documents from Trusted Public Sources

Diagnostics Forecast in the US

  • March 2017
    2 pages
  • United States  

View report >

Diagnostics Markets in the US

  • March 2017
    3 pages
  • Diagnostics  

  • United States  

View report >

Diagnostics Forecast in the US

  • February 2017
    2 pages
  • Diagnostics  

    Cancer  

    Health Care Pro...  

  • United States  

View report >

Related Market Segments :

Diagnostics

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.